Resealed erythrocytes: A Novel carrier for drug targeting

Journal of Chemical and Pharmaceutical Research

Volumn 3, Issue 2, 2011, Pages 550-565

  Sah, Abhishek Kumar ^a   Rambhade, Ashish ^a   Ram, Alpna ^b   Jain, Sunil K ^b  

^a Sagar Institute of Research Technology and Science   (India)

^b GURU GHASIDAS UNIVERSITY   (India)

Author keywords

Drug targeting; Novel carrier; Resealed erythrocytes

Indexed keywords

ANTIVIRUS AGENT; DRUG CARRIER;

ARTICLE; CELL ENCAPSULATION; CELL FUSION; CELL MEMBRANE PERMEABILITY; CROSS LINKING; CYANIDE POISONING; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; DRUG TARGETING; ENDOCYTOSIS; ERYTHROCYTE; ERYTHROCYTE STRUCTURE; HUMAN; IRON OVERLOAD; LIVER TUMOR; LYSIS; NONHUMAN; PARASITOSIS; RESEALED ERYTHROCYTE;

EID: 79954513148     PISSN: None     EISSN: 09757384     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. V S Gopal, R C Doijad, and P B Deshpande, Erythrocytes as a carrier for prednisolone- in vitro and in vivo evaluation., Pak J. Pharm. Sci, 2010 (2); 23: 194-200.
2. K K Sawant, H N Soni and R S R Murthy, Investigation on resealed erythrocytes as carrier for 5 - flurouracil, Indian J. Pharm. Sci, 2001(2); 63: 105-109.
3. B Nicholas, Retrometabolic approaches to drug targeting membrane and barrier In: Rapaka RS (editor), NIH Publication, 1995: 1-6.
4. H G Eicher and H Ramies, Survial of Gentamicine loaded carrier erythrocytes in healthy human volunteers. Eur. J. Clin. Invest. 1986 (1); 16: 39-42.
5. st edition Vallabh Prakashan, New Delhi, 1997; 86-90.
6. N Talwar and N K Jain, J. Control. Rel., 1992a; 20: 133-137.
7. S P Vyas and R K Khar, Targated and controlled drug delivery:Novel carrier system. New Delhi, CBS Publisher,New Delhi, 2004: 387-413.
8. M Hamidi and H Tajerzadeh, Carrier Erythrocytes: An Overview Drug Delivery, 2003; 10: 9- 20.
9. H Bodmann and H passow, J. Membrane Biol. 1972; 8-15.
10. S Jain and N.K Jain, "Engineered Erythrocytes as a Drug Delivery System," Indian J. Pharm. Sci. 1997;59: 275-281.
11. G M Ihler and H C W Tsang, Hypotonic Hemolysis Methods For Entrapment of Agents in Resealed Erythrocytes, Methods Enzymol. (series), 1987; 149: 221-229.
12. J R Deloach, R L Harris, and G M Ihler, Anal. Biochem.1980; 102: 220-227.
13. G M Ihler, "Erythrocyte Carriers," Pharmacol. Ther. 1983; 20: 151-169.
14. G M Iher, R M Glew and F W Schnure, "Enzyme Loading of Erythrocytes,"Proc. Natl. Acad. Sci. USA 1973; 70: 2663-2666.
15. E Pitt et al., "Encapsulation of Drugs in Intact Erythrocytes: An Intravenous Delivery System," Biochem. Pharmacol. 1983; 22: 3359-3368.
16. N Talwar and N K Jain, "Erythrocytes as Carriers of Metronidazole: In-Vitro Characterization," Drug Dev. Ind. Pharm. 1992; 18: 1799-1812.
17. S J Updike and R T Wakamiya, J. Lab. Clin.Med. 1983; 10: 679-691.
18. S J Updike, R T Wakarniya and E N Lightfoot, "Asparaginase Entrapped in Red Blood Cells: Action and Survival," Science. 1976; 193: 681-683.
19. K Adriaenssens. et al., Use of Enzyme-Loaded Erythrocytes in In Vitro Correction of Arginase Deficient Erythrocytes in Familiar Hyperargininemia, Clin. Chem. 1976; 22: 323- 326.
20. S Bhaskaran and S S Dhir, "Resealed Erythrocytes as Carriers of Salbutamol Sulphate" Indian J. Pharm. Sci. 1995; 57:240-242.
21. C Klibansky, PhD, thesis, Hebrew University, Jerusalem, Israel, 1959.
22. G M Ihler and H C W Tsang, Hypotonic Hemolysis Methods For Entrapment of Agents in Resealed Erythrocytes, Methods Enzymol. (series) 1987; 149: 221- 229.
23. J R Deloach and G M Ihler, "A Dialysis Procedure for Loading of Erythrocytes with Enzymes and Lipids," Biochim. Biophys. Acta. 1977; 496: 136-145.
24. H G Eichler et al, "In Vivo Clearance of Antibody-Sensitized Human Drug Carrier Erythrocytes," Clin. Pharmacol. Ther. 1986; 40: 300-303.
25. U Benatti et al., Comparative Tissue Distribution and Metabolism of Free Versus Erythrocyte-Encapsulated Adriamycin in the Mouse," Adv. Biosci. (series). 1987; 67: 129-136.
26. R. Kravtozoff et al, Erythrocytes as Carriers for L-Asparaginase: Methodological and Mouse In-Vivo Studies, J. Pharm. Pharmacol. 1990; 42: 473-476.
27. M C Rechsteiner, "Uptake of Protein by Red Cells," Exp. Cell Res. 1975; 43: 487-492.
28. H O Alpar and W J Irwin, "Some Unique Applications of Erythrocytes as Carrier Systems," Adv. Biosci. (series). 1987; 67: 1-9.
29. H O Alpar and D A Lewis, "Therapeutic Efficacy of Asparaginase Encapsulated in Intact Erythrocytes," Biochem. Pharmacol. 1985; 34: 257-261.
30. E Pitt, D A Lewis and R Offord, The Use of Corticosteroids En Encapsulated in Erythrocytes in the Treatment of Adjuvant Induced Arthritis in the Rat," Biochem. Pharmacol. 1983; 132: 3355-3358.
31. E Pitt et al, "Encapsulation of Drugs in Intact Erythrocytes: An In Intravenous Delivery System," Biochem. Pharmacol. 1983; 22: 3359-3368.
32. J Bird, R Best, and D A Lewis, The Encapsulation of Insulin in Erythrocytes," J. Pharm. Pharmacol. 1983; 35: 246-247.
33. N Talwar and N K Jain, Erythrocytes as Carriers of Metronidazole In-Vitro Characterization," Drug Dev. Ind. Pharm. 1992; 18: 1799-1812.
34. W N Field, M D Gamble, and D A Lewis, A Comparison of Treatment of Thyroidectomized Rats with Free Thyroxin and Thyroxin Encapsulated in Erythrocytes," Int. J. Pharm. 1989; 51: 175-178.
35. H Tajerzadeh and M Hamidi, "Evaluation of the Hypotonic Preswelling Method for Encapsulation of Enalaprilat in Human In Intact Erythrocytes," Drug Dev. Ind. Pharm. 2000; 26: 1247-1257.
36. S Jain, S K Jain and V K Dixit, "Magnetically Guided Rat Erythrocytes Bearing Isoniazid: Preparation, Characterization, and Evaluation," Drug Dev. Ind. Pharm. 1997; 23: 999-1006.
37. H Davson and J F Danielli, Dannen Conn.(Hanfer Publishing Co., Germany. 1970; 80.
38. D Billah et al.,Permeability Characteristics of Erythrocyte Ghosts Prepared Under Isoionic Conditions by a Glycol-Induced Osmotic Lysis, Biochim Biophys Acta. 1977 (3); 465: 515- 526.
39. B Deuticke, M Kim, and C Zolinev, The Influence of Amphotericin- B on the Permeability of Mammalian Erythrocytes to Nonelectrolytes, anions and Cations," Biochim. Biophys. Acta. 1973; 318: 345-359.
40. T Kitao, K Hattori, and M Takeshita, "Agglutination of Leukemic Cells and Daunomycin Entrapped Erythrocytes with Lectin In Vitro and In Vivo," Experimentia 1978; 341: 94-95.
41. W Lin et al., "Nuclear Magnetic Resonance and Oxygen Affinity Study of Cesium Binding in Human Erythrocytes," Arch Biochem Biophys. 1999; 369, 1: 78-88.
42. K Kinosita and T Y Tsong, "Hemolysis of Human Erythrocytes by a Transient Electric Field," Proc. Natl. Acad. Sci. USA, 1977; 74: 1923-1927.
43. G Saulis, The loading of human erythrocytes with small molecules by electroporation. Cell. Mol. Biol. lett. 2004; 10: 23-25.
44. S L Schrier, "Shape Changes and Deformability in Human Erythrocyte Membranes," J. Lab. Clin.Med. 1987; 110, 6: 791-797.
45. J DeLoach, "R. Encapsulation of Exogenous Agents in Erythrocytes and the Circulating Survival of Carrier Erythrocytes," J. Appl. Biochem. 1983; 5: 149-157.
46. S L Schrier, "Shape Changes and Deformability in Human Erythrocyte Membranes," J. Lab. Clin.Med. 1987;110, 6: 791-797.
47. T Y Tsong and K Kinosita, "Use of Voltage Pulses for the Pore Opening and Drug Loading, and the Subsequent Resealing of Red Blood Cells," Bibl Haematol. 1985; 51: 108-114.
48. L H Li et al, "Electrofusion Between Heterogeneous-Sized Mammalian Cells in a Pellet: Potential Applications in Drug Delivery and Hybridoma Formation," Biophys J. 1996; 71, 1: 479-486.
49. S P Vyas, and R K Khar, Targeted And Controlled Drug Delivery: Novel Carrier Systems, New Delhi, CBS publisher. 2004; 387-413.
50. M Gallo, P K Gupta, C T Hung, D G Perrier, J. Pharm. Sci. 1978; 78:190.
51. N Talwar and N K Jain, J. Control. Rel. 1992a; 20:133-141.
52. S Jain and N K Jain, Controlled and Novel Drug Delivery Systems, New Delhi, CBS publisher, New Delhi, 2007; 276-280.
53. R Green, J Miller, W Crosby, Enhancement of iron chelation by desferrioxamine entrapped in red blood cell ghosts. Blood. 1981; 57: 866-872.
54. U Zimmermann, Cellular Drug-Carrier Systems and Their PossibleTargeting In Targeted Drugs, EP Goldberg, Ed. (John Wiley & Sons,New York,). 1983; 153-200.
55. A Jaitely et al., "Resealed Erythrocytes: Drug Carrier Potentials and Biomedical Applications, Indian Drugs. 1996; 33: 589-594.
56. U Zimmermann, Jahresbericht der Kernforschungsanlage Julich G mbH (Nuclear Research Center, Julich,). 1973; 55-58.
57. A Al-Achi and M Boroujerdi. "Pharmacokinetics and Tissue Uptake of Doxorubicin Associated with Erythrocyte-Membrane: Erythrocyte- Ghosts versus Erythrocyte-Vesicles," Drug Dev. Ind. Pharm. 1990; 16: 2199-2219.
58. E Zocchi et al., "In-Vivo Liver and Lung Targeting of Adriamycin Encapsulated in Glutaraldehyde-Treated Murine Erythrocytes," Biotechnol. Appl. Biochem. 1988; 10: 555-562.
59. R C Gaudreault, B Bellemare, and J Lacroix, "Erythrocyte Membrane- Bound Daunorubicin as a Delivery System in Anticancer Treatment," Anticancer Res. 1989; 9 (4): 1201-1205.
60. M Tonetti et al.,;Construction and Characterization of Adriamycin-Loaded Canine Red Blood Cells as a Potential Slow Delivery System, Biotechnol Appl Biochem. 1990; 12 (6): 621- 629.
61. M P Summers, "Recent Advances in Drug Delivery," Pharm. J. 1983; 230: 643-645.
62. J D Berman, "Antileishmanial Activity of Red Cell Encapsulated Drugs," Adv. Biosci. (series). 1987; 67: 145-152.
63. E P Cannon et al, "Antagonism of Cyanide Intoxication with Murine Carrier Erythrocytes Containing Bovine Rhodanese and Sodium Thiosulfate," J. Toxicol. Environ. Health. 1994; 41 (3): 267-274.
64. L Pei et al, "Encapsulation of Phosphotriesterase Within Murine Erythrocytes," Toxicol. Appl. Pharmacol. 1994; 124 (2): 296-301.
65. R J Price et al, "Delivery of Colloidal Particles and Red Blood Cells to Tissue through Microvessel Ruptures Created by Targeted Microbubble Destruction with Ultrasound," Circulation. 1998; 98 (13): 1264-1267.
66. U Zimmermann, Cellular Drug-Carrier Systems and Their PossibleTargeting In Targeted Drugs, EP Goldberg, Ed. (John Wiley & Sons,New York). 1983; 153-200.
67. J R Deloach, and R Droleskey,;Survival of Murine Carrier Erythrocytes Injected Via Peritoneum, Comp. Biochem. Physiol. 1986 a; 83: 447-450.
68. T Kitao, K Hattori and M Takeshita, "Agglutination of Leukemic Cells and Daunomycin Entrapped Erythrocytes with Lectin In Vitro and In Vivo," Experimentia. 1978; 341: 94-95.
69. U Zimmermann, G Pilwat and F Riemann, "Preparation of Erythrocyte Ghosts by Dielectric Breakdown of the Cell Membrane," Biochim Biophys Acta. 1975; 375 (2): 209-219.
70. U Sprandel, A R Hubbard and R A Chalmers, "In Vivo Life Span of Resealed Rabbit Erythrocyte 'Ghosts'," Res. Exp. Med. (Berl). 1980; 177 (1): 13-17.
71. S K Jain and S P Vyas,;Magnetically Responsive Diclofenac Sodium-Loaded Erythrocytes: Preparation and In Vitro Characterization, J. Microencapsul. 1994; 11 (2): 141- 151.
72. G Flynn, L McHale and A P McHale, "Methotrexate-Loaded, Photosensitized Erythrocytes: A Photo-Activatable Carrier/Delivery System for Use in Cancer Therapy," Cancer Lett. 1994; 82 (2): 225-229.
73. L Chiarantini et al., "Modulated Red Blood Cell Survival by Membrane Protein Clustering," Mol. Cell Biochem. 1995; 144 (1): 53-59.
74. U Benatti et al,;Enhanced Antitumor Activity of Adriamycin by Encapsulation in Mouse Erythrocytes Targeted to Liver and Lungs, Pharmacol.Res. 1989; 21, (suppl 2): 27-33.
75. M Magnani et al., "Erythrocyte Engineering for Drug Delivery and Targeting," Biotechnol. Appl. Biochem. 1998; 28: 1-13.
76. A Fraternale, L Rossi and M Magnani, Encapsulation,Metabolism, and Release of 2- Fluoro-Ara-AMP from Human Erythrocytes Biochim. Biophys. Acta. 1996; 1291, 2: 149-154.
77. A C Guyton and J E Hall, "Transport of Oxygen and Carbon Dioxidein the Blood and Body Fluids," Textbook ofMedical Physiology (W.B. Saunders, Philadelphia, PA,). 1996; 513-523.
78. M C Villareal et al, "Approach to Optimization of Inositol Hexaphosphate Entrapment into Human Red Blood Cells," Adv. Biosci. (series). 1987; 67: 55-62.
79. A Arnone and M F Perutz, "Structure of Inositol Hexaphosphate Human Deoxyhaemoglobin Complex," Nature. 1974; 249: 34-36.
80. B Teisseire et al, "In Vivo Consequences of Rightward Shift of the Hemoglobin Dissociation Curve," Adv. Biosci. (series). 1987; 67: 89-94.
81. B Teisseire et al, "Physiological Effects of High-P50 Erythrocyte Transfusion on Piglets," J. Appl. Physiol. 1985; 58: 1810-1817.
82. M C Villareal et al, "Modification of Cardiac Parameters in Piglets After Infusion of IHPLoaded Red Blood Cells," Adv. Biosci. (series). 1987; 67: 81-88.
83. J F Baron et al., "Isolated Heart as a Model to Study the Effects of the Decrease in Oxygen Hemoglobin Affinity," Adv. Biosci. (series). 1987; 67: 73-78.
84. O Stucker et al., "Coronary Response to Large Decreases of Hemoglobin- O2 Affinity in Isolated Rat Heart," Am. J. Physiol. 1985; 249: 1224-1227.
85. R D Woodson and S Auerbach, "Effect of Increased Oxygen Affinity and Anemia on Cardiac Output and its Distribution," J. Appl. Physiol. 1982; 53: 1299-1306.
86. M Hamidi, H Teijerzadeh, Carrier erythrocytes an overview. Drug Delivery. 2003; 10: 9-20.